Clinical evaluation of the Vitek automated system with cards GNS 122 and 127 and VTK-R07.01 software for antimicrobial susceptibility testing of Pseudomonas aeruginosa
- 23 January 2002
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 42 (1), 71-73
- https://doi.org/10.1016/s0732-8893(01)00309-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of Gram-negative bacilli and Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1999
- Evaluation of the Vitek System to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepimeDiagnostic Microbiology and Infectious Disease, 1998
- Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United StatesDiagnostic Microbiology and Infectious Disease, 1998
- Verification and validation of procedures in the clinical microbiology laboratoryClinical Microbiology Newsletter, 1997
- Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methodsDiagnostic Microbiology and Infectious Disease, 1997